Journal of Shandong University (Health Sciences) ›› 2018, Vol. 56 ›› Issue (5): 81-84.doi: 10.6040/j.issn.1671-7554.0.2018.210
NIE Mu, NI Xiaofei, QIN Ping, YANG Dandan, LI Qiang, HOU Ming, PENG Jun, ZHANG Xiaolin, SHI Yan
CLC Number:
| [1] Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia(ITP)[J]. J Clin Med, 2017, 6(2): 16-37. [2] Cines DB, Cuker A, Semple JW. Pathogenesis of immune thrombocytopenia[J]. Presse Med, 2014, 43(2):49-59. [3] 刘月波, 周泽平, 杨红, 等. 小剂量美罗华治疗原发免疫性血小板减少症的临床疗效观察[J]. 昆明医科大学学报, 2012, 33(11):99-101. LIU Yuebo, ZHOU Zeping, YANG Hong, et al. Efficacy of low-dose rituximab for patients with immune thrombocytopenia[J]. Journal of Kunming Medical University, 2012, 33(11): 99-101. [4] Ghanima W, Godeau B, Cines DB, et al. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment[J]. Blood, 2012, 120(5): 960-969. [5] Auger S, Duny Y, Rossi JF, et al. Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis[J]. Br J Haematol, 2012, 158(3): 386-398. [6] Grace RF, Bennett CM, Ritchey AK, et al. Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia[J]. Pediatr Blood Cancer, 2012, 58(2): 221-225. [7] Zaja F, Volpetti S, Chiozzotto M, et al. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia[J]. Am J Hematol, 2012, 87(9): 886-889. [8] Reboursiere E, Fouques H, Maigne G, et al. Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles[J]. Int J Hematol, 2016, 104(1): 85-91. [9] Zaja F, Vianelli N, Volpetti S, et al. Low-dose rituximab in adult patients with primary immune thrombocytopenia[J]. Eur J Haematol, 2010, 85(4): 329-334. [10] 中华医学会血液学分会止血与血栓学组.成人原发免疫性血小板减少症诊断与治疗中国专家共识(2016年版)[J].中华血液学杂志,2016,37(2):89-93. [11] Garcia-Suarez J, Prieto A, Reyes E, et al. The clinical outcome of autoimmune thrombocytopenic purpura patients is related to their T cell immunodeficiency[J]. Br J Haematol, 1993, 84(3): 464-470. [12] 姚春花. 小剂量利妥昔单抗在原发免疫性血小板减少症患者中的应用[J]. 中外医学研究, 2016, 14(12): 162-164. [13] 隋涛, 张磊, 周泽平,等. 两种小剂量利妥昔单抗治疗方案治疗原发免疫性血小板减少症疗效比较[J]. 中华血液学杂志, 2011, 32(9): 583-586. SUI Tao, ZHANG Lei, ZHOU Zeping, et al. Efficacy and safety of two different low-dose rituximab regimens for Chinese adult patients with immune thrombocytopenia[J]. Chinese Journal of Hematology, 2011, 32(9): 583-586. [14] Stasi R, Pagano A, Stipa E, et al. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura[J]. Blood, 2001, 98(4): 952-957. [15] British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy[J]. Br J Haematol, 2003, 120(4): 574-596. [16] Brah S, Chiche L, Fanciullino R, et al. Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey[J]. Ann Hematol, 2012, 91(2):279-285. [17] 郭素丽, 陈娜飞, 魏秋平,等. 小剂量与标准剂量利妥昔单抗治疗老年慢性难治性免疫性血小板减少症的临床研究[J]. 实用医学杂志, 2013, 29(13): 2197-2198. [18] Gudbrandsdottir S, Birgens HS, Frederiksen H, et al. Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia[J]. Blood, 2013, 121(11): 1976-1981. [19] Cervinek L, Cerná O, Caniga M, et al. Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice[J]. Int J Hematol, 2012, 96(5): 594-599. [20] Khellaf M, Charlesnelson A, Fain O, et al. Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients[J]. Blood, 2014, 124(22): 3228-3236. [21] Mahévas M, Ebbo M, Audia S, et al. Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia[J]. Am J Hematol, 2013, 88(10): 858-861. [22] Gómez-Almaguer D, Tarín-Arzaga L, Moreno-Jaime B, et al. High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia[J]. Eur J Haematol, 2013, 90(6): 494-500. [23] 李丹, 胡俊, 刘顺妹,等. 标准剂量与小剂量利妥昔单抗治疗难治性免疫性血小板减少症的临床研究[J]. 医学综述, 2015(3):571-573. LI Dan, HU Jun, LIU Shunmei, et al. Clinical study of standard dose and small dose of rituximab treating refractory immune thrombocytopenia[J]. Medical Recapitulate, 2015(3): 571-573. [24] Zaja F, Battista ML, Pirrotta MT, et al. Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura[J]. Haematologica, 2008, 93(6): 930-933. [25] Cooper N, Stasi R, Cunninghamrundles S, et al. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura[J]. Br J Haematol, 2004, 125(2): 232-239. |
| [1] | XIANG Yujiao, LIU Qiang, LIU Lu, SHI Yan. Mechanism of abnormal immune response of dendritic cells in immune thrombocytopenia [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 89-97. |
| [2] | MIAO Zhuang, LIU Peilai, LU Qunshan, YAO Tianxiao, LI Songlin, LUO Desu. Early efficacy of double-column mobile bearing unicompartmental knee prosthesis in treating medial knee osteoarthritis [J]. Journal of Shandong University (Health Sciences), 2021, 59(5): 90-95. |
| [3] | LIN Yuxi, LI Chuanxi, WANG Lin, MA Wei. Sexual orientation disclosure and HIV testing uptake among men who have sex with men: chain mediating effect of HIV testing social norms and self-efficacy [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 113-119. |
| [4] | LUO Yingshu, LI Bin, XU Changqin, JIANG Junmei, XU Hongwei. Evaluation of the efficacy and complications of endoscopic treatment of 240 cases of upper gastrointestinal submucosal tumors [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 74-80. |
| [5] | JIA Jianhua, CHEN Si, WU Qianqian, XU Shuo, LI Chao, CHENG Lian, XU Shujun. Efficacy of SEEG-guided radiofrequency thermocoagulation in patients with medically intractable epilepsy [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 80-86. |
| [6] | LU Cuiyan, PAN Fang, FANG Fang. Relationship between active or passive procrastination and mindfulness, and self-efficacy of college students [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 108-113. |
| [7] | XIAO Juan, XIAO Qiang, CONG Wei, LI Ting, DING Shouluan, ZHANG Yuan, SHAO Chunchun, WU Mei, LIU Jianing, JIA Hongying. Comparison of diagnostic efficacy of two kinds of thyroid imagine reporting and data systems [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 53-59. |
| [8] | GENG Erdong, NING Juan. Efficacy of atenolol on the treatment of acute coronary syndrome complicated with arrhythmia and the prognosis [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 70-73. |
| [9] | LÜ Huimin, ZHANG Mengwei, NIU Limin, ZENG Huiai, YAN Min. Efficacy and safety of single-agent domestic docetaxel in the treatment of advanced breast cancer [J]. Journal of Shandong University (Health Sciences), 2018, 56(1): 45-49. |
| [10] | YAN Jinxiang, MENG Lei, DONG Yanan, ZHANG Aijun, YUE Hongsheng, LI Bo, ZHONG Liangjun, BAI Aiguo. Application of Solitaire FR stent in the optimized treatment of acute cerebral artery occlusion [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 49-54. |
| [11] | WANG Lili, HUO Bin, WANG Lei, WANG Hao, HOU Dingkun, HUO Xiaodong, WANG Jinhuan, ZANG Li, CAO Qiang, CHAI Shude, WANG Haitao. Meta-analysis and system evaluation of 125I implantation in the treatment of early lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 76-83. |
| [12] | LIU Songtao, SHEN Bin, LIN Hui, LI Xiangwei, WEN Zhaoke. A comparative study of total thoracoscopic mitral valve replacement under heart beating and heart arrest [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 39-43. |
| [13] | LI Xue-qin1, LI Yu-li2, SHI Wen-zhuan1. Correlation between emotional creativity and impulsiveness and self-efficacy in medical students [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(2): 90-92. |
| [14] | JU Shengtao, JIA Tanghong, NING Bin. Efficacy of periacetabular osteotomy for the treatment of developmental dysplasia of hip [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(10): 100-102. |
| [15] | LIU Lu, LIU Chuan-fang, WANG Min, TIAN Tian, YU Shuang, HE Na, SUN Yuan-xin, MA Dao-xin. The aberrant expression of microRNA-181a, microRNA-146a, microRNA-326 and microRNA-142-3p in peripheral blood of patients with immune thrombocytopenia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(12): 55-60. |
|
||
